| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030423 |
| Receipt No. | R000034739 |
| Official scientific title of the study | A skin irritation study of KMW-1 in healthy adults (phase 1) |
| Date of disclosure of the study information | 2017/12/16 |
| Last modified on | 2018/01/25 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A skin irritation study of KMW-1 in healthy adults (phase 1) | |
| Title of the study (Brief title) | A skin irritation study of KMW-1 (phase 1) | |
| Region |
|
|
| Condition | ||||
| Condition | burn | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To investigate skin irritability and the safety of a single application of KMW-1 by patch test in Japanese healthy adults |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | Skin irritability at 4 hours, 8 hours, 12hours, 24hours and 48 hours after administraion |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | KMW-1(0.09 g/g),Placebo, Deionized water (negative-controlled) and Patch test unit only will be applied on the back (paraspinal site) of the study subjects for 4 hours, 8 hours and 12 hours by using a closed-type patch test unit. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. Health volunteers
2. Japanese 3. BMI of 18.5 to 25.0 (rounded to one decimal place) |
|||
| Key exclusion criteria | 1. Does NOT have dermatological diseases such as dermatitis and eczema
2. Does NOT have history of skin rash from e.g. plaster or contact dermatitis metal, cosmetics or household appliance 3. Has a wound, scar, birthmark, or tattoo on the back (paraspinal sites) 4. Has a history of allergic reactions to medications, pineapple, papaya or specific constitutions (e.g. alcohol hypersensitivity) 5. Complicated with liver, kidney, heart diseases or hematological disorders or has a history of them 6. Regularly uses drugs 7. Has a history of drug abuse (narcotics/stimulants/psychotropics) or alcohol dependence |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Nobuyuki Kodera |
| Organization | KAKEN PHARMACEUTICAL CO., LTD. |
| Division name | Clinical Development Depertment |
| Address | 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, Japan |
| TEL | 03-5977-5111 |
| kodera_nobuyuki@kaken.co.jp | |
| Public contact | |
| Name of contact person | Keita Shoshi |
| Organization | KAKEN PHARMACEUTICAL CO., LTD. |
| Division name | Clinical Development Depertment |
| Address | 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, Japan |
| TEL | 03-5977-5111 |
| Homepage URL | |
| shoshi_keita@kaken.co.jp | |
| Sponsor | |
| Institute | KAKEN PHARMACEUTICAL CO., LTD. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KAKEN PHARMACEUTICAL CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034739 |